Chromium and Insulin Action

Completed · Phase 4

Conditions studied: Type 2 Diabetes

In brief

The effect of Chromium to improve glucose levels in diabetes is controversial. The hypothesis of the study was to evaluate the effect of supplementing the diet of individuals with Type 2 diabetes with chromium picolinate and assessing the effect on blood glucose levels and insulin sensitivity

Key facts

Study ID

NCT00283777

Run by

Pennington Biomedical Research Center

People needed

30

Starts

1998-08-01

Expected to finish

2003-04-01

Last updated by the study team

2016-04-08

Who can join

Age: 25 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetes on diet therapy or low dose oral agent -

You may not qualify if…

• Significant cardiovascular, hepatic or renal disease

Where it is running

• University of Vermont — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.